Sandra D. van der Vaart - 15 Sep 2021 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
EVP, Chief Legal Officer
Signature
/s/ Sandra D. van der Vaart
Issuer symbol
LH
Transactions as of
15 Sep 2021
Net transactions value
-$953,640
Form type
4
Filing time
17 Sep 2021, 12:20:09 UTC
Previous filing
09 Jun 2021
Next filing
04 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise $381,870 +4,500 +85% $84.86 9,765 15 Sep 2021 Direct F1, F2
transaction LH Common Stock Sale $1,335,510 -4,500 -46% $296.78 5,265 15 Sep 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Non-qualified Stock Options Options Exercise $0 -4,500 -100% $0.000000* 0 15 Sep 2021 Common Stock 4,500 $84.86 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2 Amount includes 27.7429 shares acquired on June 30, 2021 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
F3 Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2012 Omnibus Incentive Plan.
F4 The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.